Home/AlzeCure Pharma/Johan Sandin
JS

Johan Sandin

Chief Scientific Officer (CSO)

AlzeCure Pharma

AlzeCure Pharma Pipeline

DrugIndicationPhase
NeuroRestore ACD856Alzheimer's Disease (Cognitive Symptoms)Phase 2
Alzstatin ProgramAlzheimer's Disease (Disease Modification)Pre-clinical
Painless ACD440Neuropathic Pain / ErythromelalgiaPhase 2
Painless TrkA-NAMSevere Pain (e.g., Osteoarthritis)Pre-clinical